Glucagon-like peptide-1 receptor agonists induce glucose-dependent insulin secretion, beta-cell protection, and other extraglycemic benefits such as weight loss and improvement in markers of cardiovascular risk
As a dual agonist, it targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
GLP-1 is great for those who want to lose weight and Have a BMI of 30 or greater OR Have a BMI of 27 or greater with at least one weight related health condition There are a few health conditions that are contraindications to receive weight loss injections
As they drop, so does your body's ability to build muscle, burn fat, rejuvenate skin, and maintain the vitality you had when you were younger
Wang L, Yan Y, Wu L, Peng J